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Thalassemia is the most common monogenetic disorder worldwide, with 60 000 infants with thalassemia major born annually.1 Survival often depends on regular blood transfusions to correct anemia and to reduce ineffective erythropoiesis, but 
these transfusions can result in iron overload and organ failure unless chelation therapy 
is undertaken. Serum ferritin levels continue to be used as a guide to chelation but are 
unreliable, and the availability of cardiovascular magnetic resonance (CMR) T2* imag-
ing has transformed patient management by allowing organ-specific quantification of 
iron content.2,3
Countries with a high prevalence of thalassemia major have CMR, but magnet 
time is expensive and analytic expertise lacking. The aim of TIC-TOC (Thailand and 
UK International Collaboration in Thalassaemia Optimising Ultrafast CMR) was to 
investigate whether ultrafast CMR mapping could provide reliable immediate diagno-
ses of heart and liver iron content, eliminating the need for complex analysis, thus 
reducing costs to a level within local resources. The research received approval by 
the Institutional Review Board of the Faculty of Medicine at Chulalongkorn University. 
All participants provided written informed consent.
One hundred participants with thalassemia major were recruited by the local 
support group at the King Chulalongkorn Memorial Hospital in Bangkok, Thailand. 
Eleven healthy volunteers not on cardio-active medication were recruited through 
local hospital advertising to confirm normal ranges. All participants underwent 
magnetic resonance imaging scans with a 1.5-T scanner (Aera, Siemens) cali-
brated with the T1MES (T1 Mapping and ECV Standardisation in CMR) phantom.4 
The scan consisted of 10 breath holds: localizer and pilot images, myocardial 
and liver T2* and T1 mapping, anatomic half-Fourier acquisition single-shot turbo 
spin echo stack, and long-axis left ventricular steady-state free-precession cines 
with an optional short-axis cine stack (2 breath holds) if abnormal, but none were. 
Both modified look-locker inversion recovery (MOLLI) and shortened MOLLI (Myo-
Maps, Siemens) T1 mapping sequences were implemented. T2* and native T1 
maps were performed on the same mid left ventricular short-axis slice. The black-
blood T2* sequence consisted of 8 or 12 echoes (2.68–20.11 milliseconds; 
2.49-millisecond increments for the heart; 12 in the transverse plane for the liver; 
minimum echo time, 0.99 millisecond). Images were analyzed as they were ac-
quired, providing assessment of myocardial and liver iron, function, and extracar-
diac anatomy.
For the myocardial maps, a single septal region of interest was manually traced. 
For the liver T2* maps, a large region of interest was traced, avoiding vascula-
ture. Liver T1 values were obtained from the myocardial short-axis images. The 11 
healthy volunteers all had normal scans. The lower limit of normal for T1 was taken 
as 2 SD below the mean and 20 millisecond for myocardial T2*.2,3
Ferritin and hemoglobin blood levels were measured. One-year average ferritin 
values were calculated from a minimum of 3 values per patient.
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CORRESPONDENCE
Of the 100 participants invited, 97 were scanned; 2 par-
ticipants were unwell and 1 patient consented but was claus-
trophobic (Table). Visual left ventricular function assessment 
on long-axis cines was normal in all participants, including 
those with cardiac iron. In total, including test-retest, 123 
scans were performed in 2 days (12-hour working days). 
Mean scan duration was 8.3±2.4 minutes with complete 
analysis within 1 minute of the last image acquisition.
Fifteen participants had myocardial iron loading by 
T2* (10 severe, 2 moderate, 3 mild). There was good 
correlation between myocardial T2* and T1 maps (T2* 
versus MOLLI, r2=0.81; T2* versus shortened MOLLI, 
r2=0.83; both P<0.0001). All participants with low myo-
cardial iron T2* had low T1 values. Thirty participants 
with normal T2* had low T1 MOLLI values (<982 milli-
seconds). Ninety-six participants had liver iron by T2*(46 
severe, 33 moderate, 17 mild); only 1 patient had a nor-
mal liver T2* value. Liver T2* mapping correlated with 
T1 mapping (T2* versus MOLLI, r2=0.33; T2* versus 
shortened MOLLI, r2=0.36; P<0.0001).
There was a weak correlation between myocardial and 
liver T2* maps and mean ferritin values (r2=0.17 and 
r2=0.15, respectively; both P<0.0001). There was no 
correlation with ferritin in severe myocardial and liver iron.
TIC-TOC demonstrated the clinical and economic advan-
tages of ultrafast magnetic resonance imaging protocols, 
scanning 6 participants per hour for two 12-hour days, 
reducing scanning costs by a factor of ≈4. Mapping analy-
sis took minimal training, required <1 minute, and was reli-
able (data not shown). Mapping revealed a 15% prevalence 
of abnormal cardiac iron content by T2* and 45% by T1. 
High liver iron was detected in 99%. This study has demon-
strated that ultrafast scanning is achievable with the use of 
sequences available on commercially available CMRs and 
scanners. Thus, widespread adoption of this approach is 
feasible and currently being investigated by the Global-AID 
project, which is endeavoring to distribute this technology 
to multiple countries to confirm applicability and cost-effec-
tiveness and to investigate potential changes in outcomes.
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Table.  Participant Baseline Characteristics
Characteristics Value
n 97
Age, y 34.1±12.1
Sex, M/F 31/66
Height, m 1.57±0.08
Weight, kg 50.7±9.2
BSA, m2 1.48±0.16
Chelation
 DFO, n 13
 DPO, n 63
 Deferasirox, n 6
 DFO+DPO, n 5
 DPO+deferasirox, n 2
 None, n 8
MRI scanning duration, min 8.3±2.4
Myocardial T2*, ms 29.5±7.9
Myocardial iron by T2* <20 ms 
(participant frequency, %)
15 (15.5)
Liver T2*, ms 2.5±1.4
Liver iron by T2* <6.3 ms (participant 
frequency, %)
96 (98.9)
Average ferritin, μg/L 3533±2897
Hemoglobin, g/dL 8.03±1.24
Average ferritin over 1 year. Data are presented as mean±SD when 
appropriate. BSA indicates body surface area; DFO desferrioxamine; DPO, 
deferiprone; and MRI, magnetic resonance imaging. 
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